Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Clinical trial NCT01540409 · COMPLETED
Trial details
- NCT number
- NCT01540409
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-27
- Primary completion
- 2016-04-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.